1. Mousquer, G. T., Peres, A., & Fiegenbaum, M. (2021). Pathology of TB/COVID-19 co-infection: the phantom menace. Tuberculosis (Edinburgh, Scotland), 126, 102020. https://doi.org/10.1016/j.tube.2020.102020
2. Garlant, H. N., Ellappan, K., Hewitt, M., Perumal, P., Pekeleke, S., Wand, N., Southern, J., Kumar, S. V., Belgode, H., Abubakar, I., Sinha, S., Vasan, S., Joseph, N. M., & Kempsell, K. E. (2022). Evaluation of host protein biomarkers by ELISA from whole lysed peripheral blood for development of diagnostic tests for active tuberculosis. Frontiers in Immunology, 13, 854327. https://doi.org/10.3389/fimmu.2022.854327
3. World Health Organization. (2010). Multidrug and extensively drug-resistant TB (M/XDR-TB): global report on surveillance and response. World Health Organization. https://apps.who.int/iris/handle/10665/44286.
4. World Health Organization. (2015). Global tuberculosis report. 20th ed. World Health Organization. https://apps.who.int/iris/handle/10665/191102.
5. World Health Organization. (2019). Global tuberculosis report. Geneva: World Health Organization. https://www.who.int/publications/i/item/9789241565714.